What If Ventures

Two Chairs is a mental health platform founded in 2017, dedicated to making exceptional mental health care universally accessible. The company's innovative approach involves a thorough, research-backed process that pairs patients with their ideal therapists. This matching is supported by an industry-leading measurement-based care system designed to promote quicker patient improvement. With over 500 licensed therapists across 90 areas of expertise, Two Chairs serves more than 20 million covered lives. The company is recognized as a desirable workplace, receiving accolades such as the 2024 Great Place To Work and being named one of the Best Places To Work by the San Francisco Business Times.

InSite Health offers comprehensive mental health services, including psychiatric evaluations, medication management, psychotherapy, and behavioral threat assessments. They specialize in treating anxiety disorders, PTSD, addiction, depression, ADHD, autism, and behavioral disorders. Their hybrid telepsychiatry model allows for both in-person and remote sessions, ensuring convenient access to care.

NeuroFlow, Inc. is a digital health company that develops a cloud-based platform designed to enhance access to behavioral health and engage patients throughout the continuum of mental healthcare. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, NeuroFlow provides healthcare providers with tools for remote patient monitoring and integration of behavioral health across various care settings, including psychology, primary care, and pain management. The platform employs evidence-based practices to track, assess, and engage patients, promoting overall wellness and improving compliance with treatment. By utilizing patient-generated questionnaires and journaling, NeuroFlow enables individuals to monitor their mental health outcomes and achieve tangible progress. The company has established strategic partnerships with organizations like Smart Health Innovation Lab and Mental Health America to further its mission of improving mental health support and outcomes.

Motivo Consulting, Inc., operating as Motivo, is an online platform that facilitates connections between mental health therapists and clinical supervisors. Founded in 2017 and based in Atlanta, Georgia, Motivo addresses the need for pre-licensed therapists to complete mandatory supervision hours required for licensure. The platform enables users to engage in secure video conferences, allowing therapists to access a broader range of supervisors, thereby overcoming limitations in available options. Additionally, Motivo offers resources such as peer consultations, webinars, and training, enhancing the professional development of its users. With the growth of telehealth services, Motivo has positioned itself as a leader in therapist telesupervision, ensuring that mental health professionals can find appropriate supervision in a convenient and accessible manner.

Foresight Mental Health is a technology-enabled psychiatry and therapy services company that directly employs psychiatrists, therapists, and psychiatric nurse practitioners to treat patients in its clinics. The company develops technology in collaboration with its providers, leveraging software and biomedical engineering to enhance care. Through a network of clinics, it offers a broad range of mental health treatments and wellness services and maintains patient profiles and a repository of scientific research and clinical information, including genetic profiles, comprehensive symptom profiles, and brain-chemical balance estimates to inform personalized care.

Osmind Inc. is a San Francisco-based public benefit corporation founded in 2020 that specializes in developing healthcare software tailored for mental health providers and their patients. The company focuses on advancing evidence-based medicine to support individuals suffering from moderate to severe mental health conditions. Osmind's electronic health record platform is designed specifically for clinicians and researchers, facilitating interventional treatment workflows. It includes features such as journaling tools and support for health plan reimbursement, empowering healthcare professionals to implement innovative therapeutic approaches and precision psychiatry. By providing robust technology, Osmind aims to inform best practices in patient care and contribute to the development of new life-saving mental health treatments.

HealthRhythms develops a digital platform that assesses and monitors mental health conditions using deep machine learning and predictive analytics. Its solution offers real-time behavioral monitoring and personalized interventions, enabling healthcare providers to accurately measure mental health status and deliver timely care.

Mightier is a Boston-based company that develops bioresponsive video games and a family program designed to help children regulate emotions. The platform pairs gameplay with a biofeedback heart rate monitor to adjust game difficulty, encouraging kids to stay calm and in control while learning to recognize and manage emotions in daily life. Created through collaboration with Boston Children's Hospital and Harvard Medical School, Mightier aims to address behavioral and emotional challenges by teaching real-time emotion regulation skills. Founded in 2016, the company offers a program that integrates mind-body signals into interactive experiences, enabling children to practice emotional control through engaging, age-appropriate games.

Aptihealth is a technology-driven company specializing in behavioral health engagement. Its innovative platform facilitates seamless integration between physical and behavioral healthcare providers, specialists, prescribers, and patients. The platform employs proprietary screening, assessment, and treatment management protocols to deliver intelligent, virtual integrated care, enhancing patient outcomes.

Grow Therapy is a mental health technology company focused on enhancing access to quality mental healthcare. It offers therapists and prescribers a comprehensive suite of business tools and services, along with a peer community and a steady stream of matched patient referrals. This support enables practitioners to establish and expand successful in-person and virtual private practices tailored to the needs of their communities. By connecting patients with a diverse range of providers who accept their insurance, Grow Therapy facilitates improved access to mental health services across the United States. The company has built a network of thousands of providers and collaborates with major insurers, ensuring that more individuals receive the care they require.

MiResource aims to improve global mental health by connecting individuals with appropriate mental healthcare services. Its platform facilitates connections between patients and licensed therapy providers, offering information on various treatment options such as one-on-one talk therapy, medication management, and intensive outpatient programs.

Founded in 2014, Beckley Psytech is a UK-based company dedicated to developing psychedelic medicines for treating mental health disorders. It focuses on rigorous scientific research and clinical-stage drug development, aiming to provide innovative treatments for conditions like depression and anxiety.

Woebot Health is a digital mental healthcare provider that offers a platform designed to deliver personalized support and guidance. Utilizing advanced artificial intelligence and natural language processing, Woebot Health incorporates clinically proven therapeutic techniques into its services. The centerpiece of its offering is Woebot, an engaging relational agent that facilitates continuous, empathic, and user-friendly interactions. This innovative approach allows individuals and organizations to access effective mental health support seamlessly, fitting into daily life and providing help whenever needed. Woebot Health aims to enhance mental well-being through scalable digital tools, making mental health resources more accessible to a broad audience.

TRIPP is a digital wellness company that develops immersive experiences for virtual reality, augmented reality, and mobile devices to support emotional well-being. The platform combines mindfulness structures, sound frequencies, visuals, and interactive elements to influence mood—helping users feel calmer, more focused, and less stressed. Aimed at consumer households, TRIPP delivers these experiences through VR, AR, and mobile formats, grounded in research-based content. The company is headquartered in Los Angeles, California, with a satellite development office in Chicago.

Founded in 2019, Ksana Health specializes in digital mental health solutions. Its platform collects user data related to mental health and facilitates its transfer to healthcare practitioners for improved patient care.

Founded in 2013, Ellipsis Health is a technology company that uses artificial intelligence to improve behavioral health. It analyzes patient speech and clinical data to predict health outcomes and provide real-time assessments for conditions like depression.

LivNao Technologies is a Vancouver-based company that utilizes deep learning technology to monitor and enhance mental health. By passively collecting data, LivNao's platform identifies early indicators of mental health changes before they impact performance and productivity. Once a deviation is detected, the company provides timely interventions tailored to individual health plans, promoting proactive mental health management. LivNao aims to improve the quality of life for individuals and organizations alike, enabling informed decision-making for healthcare systems and insurers. Committed to maintaining privacy and security, LivNao operates in full compliance with HIPAA regulations.

Founded in 2014, Beckley Psytech is a UK-based company dedicated to developing psychedelic medicines for treating mental health disorders. It focuses on rigorous scientific research and clinical-stage drug development, aiming to provide innovative treatments for conditions like depression and anxiety.

ATAI Life Sciences is a biotechnology company focused on developing therapies for mental health disorders, leveraging psychedelic compounds and neuroscience-based approaches. It operates a platform for mental health drug discovery and development and collaborates with partners and research institutions to advance its pipeline, which includes VLS-01, a buccal-film DMT candidate for treatment-resistant depression, and EMP-01, an oral MDMA therapy for social anxiety disorder, along with a drug discovery program aimed at identifying non-hallucinogenic 5-HT2A receptor agonists for depression. The company is based in Munich, Germany, with additional offices in Berlin and London.

NeuroFlow, Inc. is a digital health company that develops a cloud-based platform designed to enhance access to behavioral health and engage patients throughout the continuum of mental healthcare. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, NeuroFlow provides healthcare providers with tools for remote patient monitoring and integration of behavioral health across various care settings, including psychology, primary care, and pain management. The platform employs evidence-based practices to track, assess, and engage patients, promoting overall wellness and improving compliance with treatment. By utilizing patient-generated questionnaires and journaling, NeuroFlow enables individuals to monitor their mental health outcomes and achieve tangible progress. The company has established strategic partnerships with organizations like Smart Health Innovation Lab and Mental Health America to further its mission of improving mental health support and outcomes.

ATAI Life Sciences is a biotechnology company focused on developing therapies for mental health disorders, leveraging psychedelic compounds and neuroscience-based approaches. It operates a platform for mental health drug discovery and development and collaborates with partners and research institutions to advance its pipeline, which includes VLS-01, a buccal-film DMT candidate for treatment-resistant depression, and EMP-01, an oral MDMA therapy for social anxiety disorder, along with a drug discovery program aimed at identifying non-hallucinogenic 5-HT2A receptor agonists for depression. The company is based in Munich, Germany, with additional offices in Berlin and London.

Osmind Inc. is a San Francisco-based public benefit corporation founded in 2020 that specializes in developing healthcare software tailored for mental health providers and their patients. The company focuses on advancing evidence-based medicine to support individuals suffering from moderate to severe mental health conditions. Osmind's electronic health record platform is designed specifically for clinicians and researchers, facilitating interventional treatment workflows. It includes features such as journaling tools and support for health plan reimbursement, empowering healthcare professionals to implement innovative therapeutic approaches and precision psychiatry. By providing robust technology, Osmind aims to inform best practices in patient care and contribute to the development of new life-saving mental health treatments.

Mindstrong Health, established in 2013 and based in Mountain View, California, specializes in remote mental health care. It offers a digital therapeutic platform that combines AI-powered technology, data, and clinical expertise to monitor and improve users' mental health. The platform tracks symptoms continuously through passive data collection from human-computer interactions, enabling evidence-based interventions and personalized support. Services include cognitive behavioral therapy, psychoeducation, crisis management, and more, helping thousands of users, including those with serious mental illness.

Foresight Mental Health is a technology-enabled psychiatry and therapy services company that directly employs psychiatrists, therapists, and psychiatric nurse practitioners to treat patients in its clinics. The company develops technology in collaboration with its providers, leveraging software and biomedical engineering to enhance care. Through a network of clinics, it offers a broad range of mental health treatments and wellness services and maintains patient profiles and a repository of scientific research and clinical information, including genetic profiles, comprehensive symptom profiles, and brain-chemical balance estimates to inform personalized care.

ATAI Life Sciences is a biotechnology company focused on developing therapies for mental health disorders, leveraging psychedelic compounds and neuroscience-based approaches. It operates a platform for mental health drug discovery and development and collaborates with partners and research institutions to advance its pipeline, which includes VLS-01, a buccal-film DMT candidate for treatment-resistant depression, and EMP-01, an oral MDMA therapy for social anxiety disorder, along with a drug discovery program aimed at identifying non-hallucinogenic 5-HT2A receptor agonists for depression. The company is based in Munich, Germany, with additional offices in Berlin and London.

Foresight Mental Health is a technology-enabled psychiatry and therapy services company that directly employs psychiatrists, therapists, and psychiatric nurse practitioners to treat patients in its clinics. The company develops technology in collaboration with its providers, leveraging software and biomedical engineering to enhance care. Through a network of clinics, it offers a broad range of mental health treatments and wellness services and maintains patient profiles and a repository of scientific research and clinical information, including genetic profiles, comprehensive symptom profiles, and brain-chemical balance estimates to inform personalized care.